Form 4 for CRL Charles River Laboratories
Accepted 2024-05-14 00:00:00 ET · period of report 2024-05-10 · accession 0001127602-24-015276 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-14 | 2024-05-10 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $226.97 | -1,304 | 23.3K | -5% | -$296.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | S | D | 1,304 | $226.97 | 23,276 | D | — | — |